These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 30123055)

  • 21. ADRA2A Germline Gene Polymorphism is Associated to the Severity, but not to the Risk, of Breast Cancer.
    Kaabi B; Belaaloui G; Benbrahim W; Hamizi K; Sadelaoud M; Toumi W; Bounecer H
    Pathol Oncol Res; 2016 Apr; 22(2):357-65. PubMed ID: 26563278
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A genetic variant in p63 (rs17506395) is associated with breast cancer susceptibility and prognosis.
    Zhang N; Huo Q; Wang X; Chen X; Long L; Guan X; Jiang L; Ma T; Hu W; Yang Q
    Gene; 2014 Feb; 535(2):170-6. PubMed ID: 24316488
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of functional genetic variants in chemokine decoy receptors on the recurrence risk of breast cancer.
    Li DD; Yang C; Shao ZM; Yu KD
    Cancer Med; 2018 Nov; 7(11):5497-5504. PubMed ID: 30358125
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of heparanase gene (HPSE-1) single nucleotide polymorphisms with gastric cancer.
    Yue Z; Song Y; Wang Z; Luo Y; Jiang L; Xing L; Xu H; Zhang X
    J Surg Oncol; 2010 Jul; 102(1):68-72. PubMed ID: 20578081
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Single nucleotide polymorphisms in human gene icb-1 and breast cancer susceptibility.
    Springwald A; Lattrich C; Seitz S; Ortmann O; Treeck O
    Cancer Invest; 2009 Jul; 27(6):669-72. PubMed ID: 19308812
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic variation in estrogen and progesterone pathway genes and breast cancer risk: an exploration of tumor subtype-specific effects.
    Nyante SJ; Gammon MD; Kaufman JS; Bensen JT; Lin DY; Barnholtz-Sloan JS; Hu Y; He Q; Luo J; Millikan RC
    Cancer Causes Control; 2015 Jan; 26(1):121-31. PubMed ID: 25421376
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Polymorphisms of the SIPA1 gene and sporadic breast cancer susceptibility.
    Hsieh SM; Smith RA; Lintell NA; Hunter KW; Griffiths LR
    BMC Cancer; 2009 Sep; 9():331. PubMed ID: 19765277
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of gene and protein expression and genetic polymorphism of CC chemokine ligand 4 in colorectal cancer.
    Shamoun L; Landerholm K; Balboa Ramilo A; Andersson RE; Dimberg J; Wågsäter D
    World J Gastroenterol; 2021 Aug; 27(30):5076-5087. PubMed ID: 34497436
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of common germline polymorphisms as prognostic factors in patients with lymph node-positive breast cancer.
    Knechtel G; Hofmann G; Gerger A; Renner W; Langsenlehner T; Szkandera J; Wolf G; Samonigg H; Krippl P; Langsenlehner U
    J Cancer Res Clin Oncol; 2010 Dec; 136(12):1813-9. PubMed ID: 20204402
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An investigation of the effects of FGFR2 and B7-H4 polymorphisms in breast cancer.
    Ozgöz A; Samli H; Oztürk KH; Orhan B; Icduygu FM; Aktepe F; Imirzalioglu N
    J Cancer Res Ther; 2013; 9(3):370-5. PubMed ID: 24125968
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combinational polymorphisms of seven CXCL12-related genes are protective against breast cancer in Taiwan.
    Lin GT; Tseng HF; Yang CH; Hou MF; Chuang LY; Tai HT; Tai MH; Cheng YH; Wen CH; Liu CS; Huang CJ; Wang CL; Chang HW
    OMICS; 2009 Apr; 13(2):165-72. PubMed ID: 19196101
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The impact of Angiopoietin-2 genetic polymorphisms on susceptibility for malignant breast neoplasms.
    Hu GN; Wang Y; Tang CH; Jin LL; Huang BF; Wang Q; Shao JK; Wang CQ; Su CM
    Sci Rep; 2022 Aug; 12(1):14522. PubMed ID: 36008514
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of BCL2-938 C>A promoter polymorphism and BCL2 gene expression on the progression of breast cancer.
    Bhushann Meka P; Jarjapu S; Vishwakarma SK; Nanchari SR; Cingeetham A; Annamaneni S; Mukta S; Triveni B; Satti V
    Tumour Biol; 2016 May; 37(5):6905-12. PubMed ID: 26662799
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association between SIRT1 Gene Polymorphisms and Breast Cancer in Egyptians.
    Rizk SM; Shahin NN; Shaker OG
    PLoS One; 2016; 11(3):e0151901. PubMed ID: 26999517
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Higher circulating levels of chemokine CCL22 in patients with breast cancer: evaluation of the influences of tumor stage and chemokine gene polymorphism.
    Jafarzadeh A; Fooladseresht H; Minaee K; Bazrafshani MR; Khosravimashizi A; Nemati M; Mohammadizadeh M; Mohammadi MM; Ghaderi A
    Tumour Biol; 2015 Feb; 36(2):1163-71. PubMed ID: 25722218
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic polymorphisms of SULT1A1 and SULT1E1 and the risk and survival of breast cancer.
    Choi JY; Lee KM; Park SK; Noh DY; Ahn SH; Chung HW; Han W; Kim JS; Shin SG; Jang IJ; Yoo KY; Hirvonen A; Kang D
    Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1090-5. PubMed ID: 15894657
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A functional HOTAIR rs12826786 C>T polymorphism is associated with breast cancer susceptibility and poor clinicopathological characteristics in a Turkish population: a hospital-based case-control study.
    Bayram S; Sümbül AT; Dadaş E
    Tumour Biol; 2016 Apr; 37(4):5577-84. PubMed ID: 26577852
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Single nucleotide polymorphisms in the p21 and bcl2 cancer susceptibility genes and breast cancer risk in Saudi Arabia.
    Alshatwi AA; Shaf G; Hasan TN; Alsaif AA; Al-Hazzani AA; Alsaif MA; Lei DK
    Asian Pac J Cancer Prev; 2011; 12(10):2607-10. PubMed ID: 22320961
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of polymorphisms in circadian pathway genes in breast tumorigenesis.
    Dai H; Zhang L; Cao M; Song F; Zheng H; Zhu X; Wei Q; Zhang W; Chen K
    Breast Cancer Res Treat; 2011 Jun; 127(2):531-40. PubMed ID: 20978934
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Significant association of combination of OCT4, NANOG, and SOX2 gene polymorphisms in susceptibility and response to treatment in North Indian breast cancer patients.
    Tulsyan S; Agarwal G; Lal P; Mittal B
    Cancer Chemother Pharmacol; 2014 Nov; 74(5):1065-78. PubMed ID: 25223935
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.